⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methane SCHEMBL10339744 | 0.74 | — | — | |
| SCHEMBL27373672 | 0.68 | — | — | |
| SCHEMBL125458 | 0.68 | — | — | |
| SCHEMBL16862328 | 0.68 | — | — | |
| SCHEMBL10372777 | 0.64 | — | — | |
| SCHEMBL8519835 | 0.64 | — | — | |
| SCHEMBL14781824 | 0.64 | — | — | |
| SCHEMBL7054910 | 0.64 | ALDH1A1 (0.38) | — | |
| SCHEMBL979693 | 0.64 | — | — | |
| SCHEMBL16761968 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8748414-B2 | Statin nanoparticles | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2014-06-10 | — | — | US | claimed |
| US-20110269830-A1 | STATIN NANOPARTICLES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2011-11-03 | — | — | US | claimed |
| EP-2355801-A1 | STATIN NANOPARTICLES | Centre National de la Recherche Scientifique (FR) | 2011-08-17 | — | — | EP | claimed |
| WO-2010049900-A1 | STATIN NANOPARTICLES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2010-05-06 | — | — | WO | claimed |
| US-20250367216-A1 | PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY | INTERCEPT PHARMACEUTICALS INC (US) | 2025-12-04 | — | — | US | disclosed |
| US-20250367217-A1 | PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY | INTERCEPT PHARMACEUTICALS INC (US) | 2025-12-04 | — | — | US | disclosed |
| US-12337003-B2 | Pharmaceutical compositions for combination therapy | INTERCEPT PHARMACEUTICALS, INC. (US) | 2025-06-24 | — | — | US | disclosed |
| US-20220280533-A1 | PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY | INTERCEPT PHARMACEUTICALS, INC. | 2022-09-08 | — | — | US | disclosed |
| US-20220280534-A1 | PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY | INTERCEPT PHARMACEUTICALS, INC. | 2022-09-08 | — | — | US | disclosed |
| EP-4035665-A1 | PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY | Intercept Pharmaceuticals, Inc. (US) | 2022-08-03 | — | — | EP | disclosed |
| US-11311557-B2 | Pharmaceutical compositions for combination therapy | INTERCEPT PHARMACEUTICALS, INC. (US) | 2022-04-26 | — | — | US | disclosed |
| EP-3253382-B1 | PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY | INTERCEPT PHARMACEUTICALS INC (US) | 2021-11-17 | — | — | EP | disclosed |
| EP-0275287-A4 | HERBICIDAL PYRONES. | DUNLENA PTY LTD (AU) | 1990-03-12 | — | — | EP | disclosed |
| EP-0275287-A1 | HERBICIDAL PYRONES | Dunlena Pty. Limited (AU) | 1988-07-27 | — | — | EP | disclosed |
| WO-1988000945-A1 | HERBICIDAL PYRONES | DUNLENA PTY. LIMITED (AU) | 1988-02-11 | — | — | WO | disclosed |
| US-4645838-A | Pyrazolopyridine compounds, and intermediates, useful as anxiolytic agents | ICI AMERICAS INC. (US) | 1987-02-24 | — | — | US | disclosed |
| EP-0094175-B1 | PYRAZOLOPYRIDINE COMPOUNDS | ICI AMERICAS INC. (US) | 1986-10-29 | — | — | EP | disclosed |
| US-4563525-A | Process for preparing pyrazolopyridine compounds | ICI AMERICAS INC. (US) | 1986-01-07 | — | — | US | disclosed |
| US-4511568-A | CNS-Depressant pyrazolopyridines | ICI AMERICAS INC. (US) | 1985-04-16 | — | — | US | disclosed |
| EP-0094175-A1 | Pyrazolopyridine compounds | ICI AMERICAS INC. (US) | 1983-11-16 | — | — | EP | disclosed |